Affibodies has been one of the most frequently used targeting ligands for cancer imaging since affibodies for human epidermal receptor 2 (HER2) and epidermal growth factor receptor (EGFR) are well-studied cancer biomarkers and very robust with pico-molar sensitivity [74]. This evidence concerns the gene EGFR and cancer.